JP2023029902A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023029902A5 JP2023029902A5 JP2022188982A JP2022188982A JP2023029902A5 JP 2023029902 A5 JP2023029902 A5 JP 2023029902A5 JP 2022188982 A JP2022188982 A JP 2022188982A JP 2022188982 A JP2022188982 A JP 2022188982A JP 2023029902 A5 JP2023029902 A5 JP 2023029902A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- iii
- amino acid
- variants
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024196183A JP2025032107A (ja) | 2017-01-12 | 2024-11-08 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1700557.0 | 2017-01-12 | ||
| GBGB1700557.0A GB201700557D0 (en) | 2017-01-12 | 2017-01-12 | Novel peptides |
| JP2019538337A JP7252895B2 (ja) | 2017-01-12 | 2018-01-11 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
| PCT/GB2018/050072 WO2018130834A1 (en) | 2017-01-12 | 2018-01-11 | Mycobacteria tuberculosis chaperonin 60.1 peptides and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538337A Division JP7252895B2 (ja) | 2017-01-12 | 2018-01-11 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024196183A Division JP2025032107A (ja) | 2017-01-12 | 2024-11-08 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023029902A JP2023029902A (ja) | 2023-03-07 |
| JP2023029902A5 true JP2023029902A5 (enExample) | 2023-04-21 |
Family
ID=58463310
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538337A Active JP7252895B2 (ja) | 2017-01-12 | 2018-01-11 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
| JP2022188982A Pending JP2023029902A (ja) | 2017-01-12 | 2022-11-28 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
| JP2024196183A Pending JP2025032107A (ja) | 2017-01-12 | 2024-11-08 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538337A Active JP7252895B2 (ja) | 2017-01-12 | 2018-01-11 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024196183A Pending JP2025032107A (ja) | 2017-01-12 | 2024-11-08 | 結核菌シャペロニン６０．１ペプチドおよびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11098090B2 (enExample) |
| EP (1) | EP3568148B1 (enExample) |
| JP (3) | JP7252895B2 (enExample) |
| CN (1) | CN110381979A (enExample) |
| AU (1) | AU2018208077B2 (enExample) |
| CA (1) | CA3049353C (enExample) |
| ES (1) | ES2970436T3 (enExample) |
| GB (1) | GB201700557D0 (enExample) |
| WO (1) | WO2018130834A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12358957B2 (en) | 2017-01-12 | 2025-07-15 | Revolo Biotherapeutics Limited | Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity |
| GB201700557D0 (en) * | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Novel peptides |
| GB201700555D0 (en) * | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Method for the treatment of a relapsing-remitting condition |
| US12331088B2 (en) | 2017-01-12 | 2025-06-17 | Revolo Biotherapeutics Limited | Method for the treatment of a relapsing-remitting condition |
| US20260115265A1 (en) | 2022-05-16 | 2026-04-30 | Revolo Biotherapeutics Limited | Methods and compositions for preventing or treating food allergies |
| US12624539B2 (en) | 2023-02-28 | 2026-05-12 | Toto Ltd. | Wall-mounted flush toilet |
| EP4698203A1 (en) | 2023-04-18 | 2026-02-25 | Revolo Biotherapeutics Limited | Methods and compositions for preventing or treating eosinophilic esophagitis |
| CN122341382A (zh) | 2023-08-15 | 2026-07-03 | 雷沃洛生物医疗有限公司 | 用于预防或治疗重度哮喘的方法和组合物 |
| WO2025255468A2 (en) | 2024-06-06 | 2025-12-11 | Miguel Guzman | Subcutaneous formulation of a peptide derived from chaperonin 60.1 |
| WO2026024894A2 (en) | 2024-07-24 | 2026-01-29 | De Alba Jorge | Sublingual formulations of a peptide derived from chaperonin 60.1 and related methods |
| WO2026150363A2 (en) | 2025-01-10 | 2026-07-16 | Revolo Biotherapeutics Limited | Compositions and methods for macrophage-selective modulation of il‑4/il‑13-mediated stat6 signaling |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0028122D0 (en) | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
| GB0226105D0 (en) | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
| FR2858936A1 (fr) | 2003-08-22 | 2005-02-25 | Diatos | Potentialisation de l'activation de prodrogues de haut poids moleculaire |
| BRPI0715027A2 (pt) | 2006-09-11 | 2013-05-28 | Univ Illinois | modificaÇÕes dos peptÍdeos derivados da cupredoxina e seus mÉtodos de utilizaÇço |
| GB0803369D0 (en) * | 2008-02-25 | 2008-04-02 | Helperby Therapeutics Ltd | Biological materials and uses thereof |
| US9075059B2 (en) | 2009-11-05 | 2015-07-07 | University Of Virginia Patent Foundation | Compositions and methods for detecting plectin-1 as a biomarker for cancer |
| GB201118201D0 (en) | 2011-10-21 | 2011-12-07 | Helperby Therapeutics Ltd | Novel peptides |
| GB201700557D0 (en) * | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Novel peptides |
-
2017
- 2017-01-12 GB GBGB1700557.0A patent/GB201700557D0/en not_active Ceased
-
2018
- 2018-01-11 EP EP18701789.2A patent/EP3568148B1/en active Active
- 2018-01-11 JP JP2019538337A patent/JP7252895B2/ja active Active
- 2018-01-11 US US16/476,064 patent/US11098090B2/en active Active
- 2018-01-11 CN CN201880017906.0A patent/CN110381979A/zh active Pending
- 2018-01-11 WO PCT/GB2018/050072 patent/WO2018130834A1/en not_active Ceased
- 2018-01-11 ES ES18701789T patent/ES2970436T3/es active Active
- 2018-01-11 CA CA3049353A patent/CA3049353C/en active Active
- 2018-01-11 AU AU2018208077A patent/AU2018208077B2/en active Active
-
2022
- 2022-11-28 JP JP2022188982A patent/JP2023029902A/ja active Pending
-
2024
- 2024-11-08 JP JP2024196183A patent/JP2025032107A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Arning et al. | Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. | |
| JP2018171063A5 (enExample) | ||
| JP4327589B2 (ja) | ３つまたはそれ以上の成分を用いた改良された自然化学的連結 | |
| JP2022503427A5 (enExample) | ||
| JP2025166834A5 (enExample) | ||
| CN119013310A (zh) | 具有改善的编辑精确度的突变的胞嘧啶脱氨酶 | |
| JP2025184979A5 (enExample) | ||
| JP2009520463A5 (enExample) | ||
| AU756110B2 (en) | Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy | |
| JP2009544333A5 (enExample) | ||
| Aimoto | Contemporary methods for peptide and protein synthesis | |
| JP2023179752A5 (enExample) | ||
| JP2024028452A5 (enExample) | ||
| CN101903400A (zh) | 使用固相和液相组合技术的促胰岛素肽合成 | |
| JP2025521082A5 (enExample) | ||
| JP2022500409A5 (enExample) | ||
| JP2021522239A5 (enExample) | ||
| JP2023540098A5 (enExample) | ||
| JP2008522954A5 (enExample) | ||
| JP2024520234A5 (enExample) | ||
| JP2024530926A5 (enExample) | ||
| WO2024059862A3 (en) | Fibroin peptides and protein fragments compositions | |
| JP2005511038A5 (enExample) | ||
| JP2025514348A5 (enExample) | ||
| JP2006507328A5 (enExample) |